Maternal depressive symptoms before conception revealed in new study

News
Article

Explore the findings from a JAMA Network Open study, uncovering the stability of maternal depressive symptoms from pregnancy through 2 years postdelivery, highlighting a need for updated public health policies and timely interventions.

Maternal depressive symptoms before conception revealed in new study | Image Credit: © Kittiphan - © Kittiphan - stock.adobe.com.

Maternal depressive symptoms before conception revealed in new study | Image Credit: © Kittiphan - © Kittiphan - stock.adobe.com.

Maternal depressive symptoms may present before conception, according to a recent study published in JAMA Network Open.

Takeaways

  • The study highlights that maternal depressive symptoms can manifest before conception, challenging previous assumptions that linked such symptoms primarily to postpartum periods.
  • The inconclusive data on prepartum vs postpartum onset of depressive symptoms underlines the importance of understanding when maternal depressive symptoms first emerge.
  • The study underscores the significance of defining the onset of depressive symptoms to implement effective strategies for mental health support.
  • The study involved a substantial sample size of 11,563 pregnant women across seven diverse cohorts, utilizing the Edinburgh Postnatal Depression Scale (EPDS) and the Center for Epidemiological Studies-Depression (CES-D) for evaluation.
  • The research identified 3 consistent trajectory groups of maternal depressive symptoms after childbirth: low, mild, and high. The stability of these trajectories from pregnancy to 2 years post-delivery suggests a persistent impact of maternal depressive symptoms.

There is an association between maternal mental health and developmental outcomes in offspring, but data on prepartum vs postpartum onset of depressive symptoms remains inconclusive. It is vital to define when depressive symptoms first emerge in order to provide timely interventions.

Investigators conducted a study to assess the timing of onset and stability of maternal depressive symptoms. Data was obtained from 7 different, prospective longitudinal community-based cross-continental cohorts including 11,563 pregnant women. Depressive symptoms were measured at multiple perinatal time points in all cohorts.

Data on self-reported maternal depressive symptoms was gathered from pregnancy up to 2 years postdelivery and evaluated using either the Edinburgh Postnatal Depression Scale (EPDS) or the Center for Epidemiological Studies-Depression (CES-D). There are 10 items in the EPDS and 20 items in the CES-D, which measure the frequency of common depressive symptoms.

Six of the 7 cohorts received the EPDS, while the final cohort received the CES-D. Covariates included maternal age, educational level, ethnicity, and marital status. Data analysis was completed in R Project for Statistical Computing version 4.1.1.

Participants were aged a mean 29 years, with 4.9% being East Asian, 2.6% Southeast Asian, and 87.6% White. Most women were married or had a partner at recruitment. Investigators found 3 consistent trajectory groups of maternal depressive symptoms after childbirth: low, mild, and high. The mean trajectory across all participants remained stable from pregnancy to 2 years after childbirth.

When examining the trajectory of maternal depressive symptoms with probably depression, indicated by an EPDS score of 15 or more during pregnancy or 13 or more after childbirth, investigators observed a stable trajectory of maternal depressive symptoms during the perinatal period.

These results indicated maternal depressive symptoms are apparent during pregnancy and remain stable into the perinatal period. Investigators concluded maternal depressive symptoms may often appear before conceptions, indicating a need to update public health policy.

Reference

Kee MZL, Cremaschi A, De Iorio M, et al. Perinatal trajectories of maternal depressive symptoms in prospective, community-based cohorts across 3 continents. JAMA Netw Open. 2023;6(10):e2339942. doi:10.1001/jamanetworkopen.2023.39942

Related Videos
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Unlocking the power of oxytocin | Image credit: drannacabeca.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.